Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0STSQ8
Tue, 19.11.2024
M1 Kliniken AG
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million
Beauty segment growth driver with sales +33.5% to EUR 71.02 million
EBIT in the Beauty segment +30.4% to EUR 16.26 million
Medium-term target c [ … ]
Tue, 03.09.2024
M1 Kliniken AG
Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million
Earnings per share increased from EUR 0.17 to EUR 0.53
Beauty segment: sales +30.6% and EBIT +24.3%
Profitable growth to be continued
Berlin, 03.09.2024 – [ … ]
Fri, 21.06.2024
M1 Kliniken AG
M1 Kliniken AG: Management Board confirms growth targets
Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG.
Attila Strauss emphasis [ … ]
Fri, 21.06.2024
M1 Kliniken AG
M1 Kliniken AG: Management Board confirms growth targets
Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG.
Attila Strauss emphasis [ … ]
Tue, 11.06.2024
M1 Kliniken AG
M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
Berlin, 11 June 2024 - Kilian Brenske, member of the Management Board since 2022, has asked the Supervisory Board to terminate his position on the Management Board for private reasons. The areas of national and international expansion, marketing, purchasin [ … ]
Thu, 06.06.2024
M1 Kliniken AG
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Group sales increase by 9.6% to EUR 84.7 million in Q1 2024
Growth driver Beauty segment: sales +18.2% and EBIT +50%
Strong operating performance should continue for the rest of the year
Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A [ … ]
Thu, 06.06.2024
M1 Kliniken AG
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Group sales increase by 9.6% to EUR 84.7 million in Q1 2024
Growth driver Beauty segment: sales +18.2% and EBIT +50%
Strong operating performance should continue for the rest of the year
Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A [ … ]
Thu, 23.05.2024
M1 Kliniken AG
M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
Group sales increase by 10.9% to € 316.3 million in 2023
Highly profitable beauty segment drives growth with an increase of 17.6% to EUR 70.8 million
Consolidated net profit (after minority interests) improved from E [ … ]
Thu, 23.05.2024
M1 Kliniken AG
M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
Group sales increase by 10.9% to € 316.3 million in 2023
Highly profitable beauty segment drives growth with an increase of 17.6% to EUR 70.8 million
Consolidated net profit (after minority interests) improved from E [ … ]
Thu, 18.04.2024
M1 Kliniken AG
M1 Kliniken AG publishes preliminary figures for financial year 2023:
M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million and the Group's equity increases to € 143.7 million.
Strong sales growth of 18% in the Beauty segment from € 60.2 million to € 70.8 million.
Four locatio [ … ]